COVID-19 Vaccination: A Lifeline for Pregnant Individuals and Their Offspring
A groundbreaking study led by the University of British Columbia (UBC) has revealed the profound impact of COVID-19 vaccination on pregnant women and their babies. The research, published in JAMA, analyzed data from nearly 20,000 pregnancies across Canada, demonstrating a significant reduction in severe outcomes for both mothers and their newborns.
The study found that vaccinated pregnant individuals were 60% less likely to be hospitalized and a staggering 90% less likely to require intensive care during COVID-19 infection. Moreover, vaccination played a pivotal role in preventing premature births, with a 20% reduction during the Delta wave and a remarkable 36% decrease during the Omicron wave. Interestingly, the analysis showed that vaccination during pregnancy yielded even lower rates of preterm birth and stillbirth compared to vaccination before pregnancy.
Dr. Deborah Money, a professor of obstetrics and gynecology at UBC and the study's senior author, emphasized the importance of these findings, stating, 'Our findings provide clear, population-level evidence that COVID-19 vaccination protects pregnant people and their babies from serious complications. Even as the virus evolved, vaccination continued to offer substantial benefits for both mother and child.'
This study, conducted by the national CANCOVID-Preg surveillance network, is one of the largest datasets on COVID-19 and pregnancy globally. It highlights the safety and effectiveness of COVID-19 vaccination during pregnancy, dispelling any lingering doubts.
The research also addresses evolving vaccine guidelines for pregnant women. While some jurisdictions have been hesitant to recommend COVID-19 vaccination during pregnancy, the findings strongly support public health guidance. Dr. Elisabeth McClymont, the lead author and assistant professor in UBC's department of obstetrics and gynecology, advises, 'There is never a bad time to be vaccinated, whether you're currently pregnant or planning a pregnancy. But our data suggest there may be added benefits to receiving the vaccine during pregnancy.'
The study's pan-Canadian effort included data from nine provinces and one territory, using population-based health data to track outcomes from nearly 20,000 pregnancies affected by SARS-CoV-2 between April 2021 and December 2022. Even after adjusting for various factors, vaccination remained associated with significantly lower hospitalization risks.
Beyond COVID-19, the study underscores the importance of including pregnant individuals in vaccine research and future respiratory virus preparedness. Dr. McClymont emphasizes, 'Pregnancy is a unique period of vulnerability but also of opportunity for prevention. This study reinforces how vaccination can make a real difference for maternal and newborn health.'
The study was funded by the Public Health Agency of Canada, the COVID-19 Immunity Task Force, the Canadian Institutes of Health Research, and the BC Women's Health Foundation.
This research provides timely evidence to inform policy discussions, reinforcing the safety and efficacy of COVID-19 vaccination during pregnancy, and emphasizing the importance of protecting both mothers and their babies.
